Marianne Späne – Executive Vice President Global Business Development, Marketing and Sales – Siegfried
Click HERE to download the PDF version
CURRENTLY WHAT PARTS OF THE MARKET ARE MOST IMPORTANT FOR SIEGFRIED AND WHAT CAN WE EXPECT IN THE FUTURE?
We constantly see increasing outsourcing activity in small molecules, as companies are more and more concentrating in the core business of marketing, R&D and scouting. Due to stringent compliance requirements, many companies are now coming back from Eastern Europe and returning to Western suppliers like Siegfried, and considering both compliance and cost. Overall, this trend has helped us. Additionally, we recently acquired 3 BASF facilities, which greatly expanded our capacity. We are mostly active in small molecules, but we recently began filling activity for large molecules as well.
ARE YOU GOING TO EXPAND INTO BIOLOGICS THEN?